Back to search

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial

Data up to Jan 2025

Published2002
Citations1,954
References23

Total Citations Per Year

Abstract

References (23)

Tamoxifen for early breast cancer: an overview of the randomised trials

1998 • 4,082 citations

A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive Tumors

1989 • 1,471 citations

Anastrozole Is Superior to Tamoxifen as First-Line Therapy for Advanced Breast Cancer in Postmenopausal Women: Results of a North American Multicenter Randomized Trial

2000 • 990 citations

Anastrozole Versus Tamoxifen as First-Line Therapy for Advanced Breast Cancer in 668 Postmenopausal Women: Results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability Study

2000 • 841 citations

Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma

2001 • 567 citations

Risk and prognosis of endometrial cancer after tamoxifen for breast cancer

2000 • 521 citations

Endocrine Treatment of Breast Cancer in Women

1990 • 403 citations

Tamoxifen Therapy for Breast Cancer and Endometrial Cancer Risk

1999 • 348 citations

Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer

1996 • 341 citations

Randomized Trial of Two Versus Five Years of Adjuvant Tamoxifen for Postmenopausal Early Stage Breast Cancer

1996 • 258 citations

Tamoxifen and risk of idiopathic venous thromboembolism

1998 • 183 citations

Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma

1998 • 170 citations

Menopause, oestrogens and arthritis

2000 • 136 citations

Pharmacokinetics of anastrozole and tamoxifen alone and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women: a sub-protocol of the ‘Arimidex™ and Tamoxifen Alone or in Combination’ (ATAC) trial

2001 • 129 citations

[Aromatase inhibitors and arthralgia].

2011 • 59 citations

Gynaecological monitoring during tamoxifen therapy

1994 • 58 citations

Recent advances in endocrine therapy of breast cancer

1997 • 53 citations

Postchemotherapy rheumatism.

1993 • 43 citations

Rheumatoid Symptoms Following Breast Cancer Treatment

1999 • 27 citations

Future possibilities in the prevention of breast cancer: Breast cancer prevention trials

2000 • 26 citations

The effect of anastrozole (Arimidex™) on serum lipids — a randomized comparison of Anastrozole (AN) vs Tamoxifen (TAM) in Postmenopausal women with Advanced Breast Cancer

2001 • 25 citations

ADJUVANT TAMOXIFEN IN BREAST-CANCER-TREATMENT IN POSTMENOPAUSAL WOMEN - OCCURRENCE OF THROMBOEMBOLIC COMPLICATIONS

1994 • 22 citations

How are bisphosphonates used today in breast cancer clinical practice?

2001 • 8 citations

Cited By (0)

No citing papers found in database

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant… (2002) – The Lancet | Metascience Observatory Explorer